Showing 1 - 20 results of 126 for search '"Bone marrow transplant"', query time: 0.07s Refine Results
  1. 1
  2. 2

    Fatal Fulminant Hepatic Failure from Adenovirus in Allogeneic Bone Marrow Transplant Patients by Jatin M. Vyas, Wayne A. Marasco

    Published 2012-01-01
    “…We report two cases of fatal hepatic failure in patients who received matched unrelated bone marrow transplantation. Both patients presented with high fevers, abnormal liver functions tests, and hypodense lesions in the liver by CT scan. …”
    Get full text
    Article
  3. 3

    Association of Human Lymphocyte Antigens with Obstructive Airways Disease after Bone Marrow Transplantation by David Spaner, Jeffrey Lipton, Charles K Chan

    Published 1996-01-01
    “…BACKGROUND: Obstructive airways disease (OAD) is a known complication of allogeneic bone marrow transplantation. The etiology of OAD is unknown but is probably multifactorial. …”
    Get full text
    Article
  4. 4

    Disseminated Soft Tissue Infection and Sepsis with Stenotrophomonas maltophilia in a Bone Marrow Transplant Patient by Jeffrey H Lipton, Kelly S MacDonald

    Published 1996-01-01
    “…A 32-year-old female presented with aplastic anemia and subsequently underwent a one-antigen mismatched bone marrow transplant from her brother. She failed to engraft and a second graft was attempted. …”
    Get full text
    Article
  5. 5

    A non-conditioned bone marrow transplantation mouse model to study clonal hematopoiesis and myeloid malignancies by Sofia Bentivegna, Marwa Almosailleakh, Lin-Pierre Zhao, Mikkel Bruhn Schuster, Sébastien Benquet, Alexander Balhuizen, Helga Fibiger Munch-Petersen, Lene Dissing Sjö, Mads Hald Andersen, Nicolas Dulphy, Bo Porse, Kirsten Grønbæk

    Published 2025-01-01
    “…Individuals with CHIP have an increased risk of developing hematological malignancies, atherosclerotic cardiovascular disease, and all-cause mortality. Bone marrow transplantation (BMT) of cells carrying CHIP mutations into irradiated mice are useful procedures to investigate the dynamics of clonal expansion and potential therapeutic strategies, but myeloablative conditioning can induce confounding effects. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8

    The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation by Monika Conchon, Sabri S. Sanabani, Israel Bendit, Carla Luana Dinardo, Lucia Dias, Dalton de Alencar Fischer Chamone, Pedro Enrique Dorlhiac-Llacer, Frederico Luiz Dulley

    Published 2009-01-01
    “…We describe the response of imatinib as lifesaving treatment of chronic myeloid leukemia (CML) relapse in seven patients who underwent allogeneic bone marrow transplantation (alloBMT) at our institution over a period of 4 years. …”
    Get full text
    Article
  9. 9

    Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade by Sinda Bigenzahn, Ines Pree, Christoph Klaus, Nina Pilat, Benedikt Mahr, Elisabeth Schwaiger, Patrick Nierlich, Friedrich Wrba, Thomas Wekerle

    Published 2016-01-01
    “…Mixed chimerism and tolerance can be successfully induced in rodents through allogeneic bone marrow transplantation (BMT) with costimulation blockade (CB), but varying success rates have been reported with distinct models and protocols. …”
    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia by Terrie Flatt, Kathleen Neville, Karen Lewing, Jignesh Dalal

    Published 2012-01-01
    “…Now 30 months after bone marrow transplant the patient is without evidence of aspergillosis or leukemia.…”
    Get full text
    Article
  16. 16
  17. 17
  18. 18

    A Novel Case of Symptomatic BK Viraemia in a Patient Undergoing Treatment for Hodgkin Lymphoma by Jacinta Perram, Jane Estell

    Published 2014-01-01
    “…Symptomatic BK viral infection in the immunocompromised host is well described, most commonly seen in renal transplant recipients, bone marrow transplant recipients, and HIV positive patients. …”
    Get full text
    Article
  19. 19

    Pleuroparenchymal Fibroelastosis as a Late-Onset Pulmonary Toxicity after Treatment with Anticancer Chemotherapy for High-Risk Neuroblastoma by Satoshi Yokoyama, Risa Kanai, Daisuke Fukao, Keigo Hamahata

    Published 2024-01-01
    “…In pediatrics, it has been described in patients with a history of malignancy who have received a bone marrow transplant, chemotherapy, or radiotherapy. It is characterized by pleural thickening, fibrosis, subpleural elastosis, and intraalveolar collagen deposits. …”
    Get full text
    Article
  20. 20

    Evaluation of Quality of Life and Care Needs of Turkish Patients Undergoing Hematopoietic Stem Cell Transplantation by Neslisah Yasar, Semiha Akin

    Published 2016-01-01
    “…Their quality of life was assessed using Functional Assessment of Cancer Therapy-Bone Marrow Transplant Scale. The mean patient age was 44.99 ± 13.92 years. …”
    Get full text
    Article